The department also plans to launch an alternative approach to consulting on future adjustments, using direct engagement through workshops with industry and patient groups. Importantly, this still includes an option to submit written evidence, ensuring anyone has the opportunity to have their say.
Proposed 2026 changes to the statutory scheme for branded medicines pricingProposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.www.gov.uk